TrialOpen forum infectious diseases2025

Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World.

Alejandro de Gea-Grela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.